Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Price to Earnings (2013 - 2026)

Analysis

Rezolute (RZLT) Price to Earnings (2013 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Rezolute 477.02 Mn 477.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -18.16
Dec 31, 2025 -9.90
Sep 30, 2025 -47.19
Jun 30, 2025 -15.90
Mar 31, 2025 -9.29
Dec 31, 2024 -18.85
Sep 30, 2024 -22.02
Jun 30, 2024 -10.38
Mar 31, 2024 -8.59
Dec 31, 2023 -3.67
Sep 30, 2023 -4.68
Jun 30, 2023 -7.94
Mar 31, 2023 -6.30
Dec 31, 2022 -7.86
Sep 30, 2022 -14.10
Jun 30, 2022 -4.99
Mar 31, 2022 -4.70
Dec 31, 2021 -5.90
Sep 30, 2021 -7.99
Jun 30, 2021 -16.85